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ABSTRACT

EFFECT OF LONG-TERM HIGH-ALTITUDE HYPOXEMIA AND DEVELOPMENT
ON MYOCARDIAL ALPHA,-ADRENERGIC RECEPTORS AND SIGNAL
TRANSDUCTION PATHWAYS

by
Bihong T. Chen

To determine the developmental changes in myocardial a1-adrenergic receptor system,
we employed [3H-Prazosin] binding technique to characterize at-adrenergic receptors in
both fetal and adult sheep myocardial ventricular membrane preparations. Myocardial ar
adrenergic receptor density (Bmax) declined during developmental process with both fetal
left ventricle(LV) and fetal right ventricle(RV) having significantly more binding sites than
respective adult ventricles. We also demonstrated that the positive inotropic response to the
a j-adrenergic agonist phenylephrine did not differ significantly between the fetal and adult
ventricles.
The present study also investigated the effect of long-term high-altitude hypoxemia on
the 04- and Pj-adrenergic receptor interaction in the heart. The interactions between two
receptor systems were examined by prior stimulation of muscles with ar adrenergic
agonist phenylephrine (PHE). Hypoxic left ventricle without prior phenylephrine
stimulation produced greater response to isoproterenol stimulation {maximal tension
developed (Tmax, g/mm2 =: 1.16 ± 0.18)}; than normoxic left ventncle without prior
phenylephnne stimulation {maximal tension developed (Tmax, g/mm2 =: 0.41 ± 0.05)}
(p<0.01). Myocardial ar and

adrenergic antagonistic interaction was observed only in

hypoxic LV. In conclusion, chronic hypoxemia augmented isoproterenol dose-responses

in hypoxic left ventricle. Phenylephrine antagonized effects of isoproterenol in hypoxic left
ventricle indicating an Qj- and

adrenergic interaction during long-term high-altitude

hypoxemia.
To determine the effects of long-term high-altitude hypoxemia on myocardial Qjadrenergic receptor system and Ins(l,4,5)P3 (IP3) responses, we employed [3H-Prazosin]
binding technique and Ins(l,4,5)P3 assay to characterize at-adrenergic receptors and
Ins( 1,4,5)P3 in the sheep myocardial preparations. Long-term high-altitude hypoxemia
significantly depressed myocardial a j-adrenergic receptor density (Bmax in fmol/mg) in
fetal right ventricle (RV). In contrast, it did not affect the dissociation constant (Kd).
Long-term hypoxemia also significantly decreased Ins(l,4,5)P3 production in response to
phenylephrine stimulation in the fetal right ventricle. In conclusion, myocardial cqadrenergic receptor density and Ins(l,4,5)P3 production in response to agonist stimulation
in the fetal right ventricle were decreased as result of long-term high-altitude hypoxemia.
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CHAPTER ONE
INTRODUCTION

Myocardial a,- adrenergic receptors have been found in almost all mammalian
species. The undisputed existence of this receptor system has been well recognized
through functional contractile study of a,- adrenergic specific agonists such as
phenylephrine and methoxamine. In addition, this receptor system has been identified by
specific radioligand studies and subsequent isolation and cloning of the receptor
molecules. The possible mechanisms of a,- adrenergic receptor-mediated effects in
contraction, signal transduction, cellular metabolism and electromechanical coupling
have been thoroughly reviewed (Endoh,1994, Terzic 1993, Fedida 1993). This overview
focuses on the different characteristics of ar adrenergic receptors from that of pr
adrenergic receptors, species difference and developmental changes of myocardial a,adrenergic receptors, and a,- adrenergic receptor response under pathological conditions.

Myocardial oq- adrenergic receptors and subtypes. Three components to the inotropic
response to a,- adrenergic stimulation have been documented in rat papillary muscle.
They are: a transient positive inotropism, followed by a transient negative inotropism,
and then continued by a sustained positive inotropism (Otani H et al., 1987). It has also
been shown that the initial inotropic response to phenylephrine stimulation is diminished
by inhibition of inositol phosphate formation with neomycin. Therefore, it appears that
the increase of intracellular Ins(l,4,5)P3 is responsible for the initial positive inotropic
response. On the other hand, the sustained positive inotropism may be mediated by
diacylglycerol (DAG) and Protein Kinase C (PKC). But no conclusive data is available
in regard to the role of PKC on inotropism. Studies so far have generated conflicting
1
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findings. Hartmann HA et al (1988) showed that administration of phorbol esters exerted
a negative inotropic effect on cardiac myocytes. However, other investigators have found
that phorbol esters exert a positive inotropic effect or could potentiate the positive
inotropic response to phenylephrine (Otani H et al, 1987). More study is needed to
clarify this issue.
Myocardial a,- adrenergic receptors can be further subdivided into at least two
pharmacologically distinct subtypes (Han et ah, 1987). These subtypes, cc1A and a1B can
be differentiated according to their sensitivity toward selective antagonists. The oc1A subtype has a higher affinity for the antagonists 5-methyle-urapidil, and WB-4101. The
a)B -subtype is irreversibly alkylated by chlorethylclonidine (CEC). It has been shown
that 20% of a,- adrenergic receptors belong to the a,A -subtype and the remaining 80% of
the binding sites may correspond to the aIB-subtype (GroP & Hanft, 1988).
Evidence has shown that these two a,- adrenergic receptor subtypes are, linked to
different signal transduction pathways and effector systems. It has been suggested that
the a]A subtype primarily promotes the influx of extracellular calcium through
dihydropyridine-sensitive channels, while the a1B-subtype participate in the signal
transduction pathway via phosphoinositide pathway (Minneman K et al., 1988). The a1B subtype appears to be involved in positive inotropism. Molecular cloning has
demonstrated at least four distinct subtypes: a,A a1B alc and a1D (Price DT et ah, 1994).
However, the relationship between cloned a,- adrenergic receptors and
pharmacologically distinct subtypes is not completely understood.

Comparison between a,- and (3,- adrenergic receptor systems. There are distinct
differences in the inotropic effects of these two receptor systems. Compared to the (3,adrenergic response, myocardial a,- adrenergic receptor stimulation causes a smaller
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positive inotropic response, which takes much longer time to develop. It has been shown
that ar adrenergic stimulation can cause a positive inotropic effect, but which amounts to
only 60% of the response to (3,- adrenergic stimulation (Hescheler J et al, 1988). Also,
a,- adrenergic stimulation increases twitch duration in isolated myocardium by
prolonging both the contractile and relaxation phases, in contrast to (3,- adrenergic
stimulation which shortens both the contractile and relaxation phases of the contraction.
Furthermore, electrophysiological studies show that myofibrillar responsiveness to Ca2+
mediated through a,- and p,- adrenergic receptors change reciprocally, with
phenylephrine increasing it and isopreterenol decreasing it (Encoh & Blinks, 1988). This
increased calcium sensitivity of the myofilaments is probably related to activation of
Na7H+ exchange and alkalinization of the sarcoplasm. By sensitizing myofilaments to
Ca2+, a,- adrenergic agonists could increase contractility in the heart without increasing
oxygen demand.
There are also major differences in the mechanisms for a,- and p,- adrenergic
receptor function (Figure 1). Since the first observation that phosphoinositide
metabolism (PI) was regulated by adrenergic system in the heart (Gaut & Huggins, 1966),
studies have demonstrated the role of inositol phosphates in signal transduction system.
It is now generally accepted that phenylephrine stimulates a,-adrenergic receptors in the
heart muscle, which in turn activates phospholipase C. This phosphoinositide-specific
enzyme mediates PtdIns(4,5)P2 hydrolysis to generate Ins(l,4,5)P3 and diacylglycerol
(DAG) (Berridge 1993). Ins(l,4,5)P3 enhances the release of calcium from intracellular
stores such as the sarcoplasmic reticulum to enhance contraction. Scholz et al (1991)
demonstrated in their study with isolated electrically stimulated perfused rat heart that the
increase in Ins(l,4,5)P3 preceded the increase in force of contraction. They also showed
that Ins(l,4,5)P3 and force had similar dose-responses to phenylephrine stimulation.
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Furthermore, they also showed the role of Ins(l,4,5)P3 both as a second messenger and as
the molecular link between a,-adrenergic receptor stimulation and inotropic responses in
cardiac muscle. Thus, their study demonstrated the causal relationship between
Ins(l,4,5)P3 production and positive inotropism.
As shown in Figure 1, stimulation of a,-adrenergic receptors may increase the
sensitivity of the contractile proteins for Ca2+ (Pathway 1). This is probably related to
activation of Na7H+ exchange and alkalinization of the sarcoplasm. In addition, oc,adrenergic receptor stimulation activates Phospholipase C. This phosphoinositidespecific enzyme mediates PtdIns(4,5)P2 hydrolysis to generate Ins(l,4,5)P3 and
diacylglycerol (DAG). Ins(l,4,5)P3 releases calcium from intracellular stores, such as
sarcoplasmic reticulum, to enhance contraction (Pathway 2). Furthermore, a,-adrenergic
receptor activation may modulate p,- adrenergic receptor system response (Pathway 3).
In isolated rat heart stimulated with norepinephrine, the aj-adrenergic receptor-mediated
component contributes about 25 % of the final inotropic effect, whereas the p- adrenergic
receptor component accounts for 75% (Skomedal T et al., 1988). Although it is not easy
to observe inotropic response to a,-adrenergic stimulation in vivo due to the predominant
p- adrenergic effect, sympathomimetic amines including adrenaline and norepinephrine
have been shown to induce positive inotropic effects via activation of a,-adrenergic
receptors in the low concentration range, and via the p- adrenergic receptors in the higher
concentration range (Endoh M, 1991). There are both antagonistic and synergistic
interactions between the a,- and P- adrenergic receptor systems. Barrett S et al (1993)
showed that a,-adrenergic receptor stimulation inhibited accumulation of cellular cAMP
in rat cardiac myocytes, due to activation of cAMP-phosphodiesterase. Because cAMP is
the second messenger modulating p- adrenergic receptor activation, reduced cAMP
production results in inhibition of P- adrenergic receptor function. This antagonistic
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Figure 1: Activation of a-Adrenoceptors and Its Possible Role in Modulating the Effects
of P-Adrenoceptor System in Mammalian Cardiac Muscle.
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interaction is further supported by direct contractile studies of whole heart preparations
(Osnes JB et ah, 1989, Skomedal T et ah, 1988). These studies indicated a mutual
attenuation of the function of both a,- and [3- adrenergic receptor systems in the heart, in
that p~ adrenergic stimulation reduced the a,- adrenergic effect by about 50%, while a,adrenergic stimulation attenuated the (3- adrenergic effect by about 20-25%. On the other
hand, there are studies demonstrating synergism between these two receptor systems.
Butterfield MC et al (1993) showed that ar adrenergic receptor mediated responses were
potentiated following chronic

adrenergic stimulation in the rat heart. Contradictory

findings regarding a,- and p- adrenergic receptor interaction has prompted more vigorous
study in this field.

Species differences and developmental changes in myocardial a,-adrenergic
receptors. Both the density and inotropism of a,-adrenergic receptors vary with species
and age. Rat and rabbit myocardium possess a high density of a,-adrenergic receptor
binding sites (167 and 191 fmol/mg protein, respectively) when compared with dog, and
feline heart (5, and 15 fmol/mg protein, respectively) (Mukherjee et al., 1983).
Developmental changes in the density of myocardial a,-adrenergic receptors were
observed in rabbit, rat and dog hearts (Nakanishi et al., 1989). In all the species studied,
a,-adrenergic receptor density in the newborn was greater than that found in the adult.
Using [l2T]IBE2254 as a ligand, del Balso et al. (1990) found 220 fmol/mg a,-adrenergic
receptors in 1 month-old dogs versus 23 fmol/mg in the adult. This decline in receptor
density may be due to diminished levels of a,-adrenergic receptor mRNA as determined
by Northern blot analysis in the aging myocardium (Kimball et al., 1991). No age-related
difference in receptor affinity have been described.
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There is also an apparent dissociation of receptor density and inotropism with
development in myocardial a,-adrenergic receptors. In rat, rabbit and dog heart,
myocardial a,-adrenergic receptor density decreases while positive inotropism to agonist
stimulation increases with development. This could be due to the developmental
differences in subcellular organelles and the calcium releasing effect of Ins(l,4,5)P3. The
myocardium of newborn rabbit has been shown to be less sensitive to caffeine, an
activator of Ca2+ release from the sarcoplasmic reticulum (George BL et ah, 1984). In
addition, Nakanishi et al (1984) showed that the sarcoplasmic reticulum was
underdeveloped in the premature heart. Therefore, it is possible that the calcium
releasing effect of inositol triphosphate from this intracellular organelle and the resulting
positive inotropic effect may be reduced in the young myocardium.

Myocardial oq-adrenergic receptors under pathological conditions. It has been
proposed that a!-adrenergic receptors might serve as a reserve mechanism to maintain
myocardial responsiveness to catecholamine under conditions in which the (3- adrenergic
receptors are not functional (Osnes et ah, 1985). Studies have shown that aradrenergic
receptors are involved in cardiac dysfuntions, such as cardiac ischemia, cardiac
hypertrophy and cardiac arrhythmia.
Myocardial (Xj-adrenergic activation increases the automaticity of latent
pacemakers and therefore enhances the genesis of specific arrhythmia (Sheridan, 1986).
During myocardial ischemia and reperfusion, a,-adrenergic receptors increase in
numbers, which has been indicated to contribute to reperfusion-induced arrhythmia. This
is supported by evidence showing that the a,-adrenergic blocker prazosin possesses
potent antiarrhythmic effects in ischemia-reperfusion damage (Kurz T et ah, 1991). The
mechanism for generation of arrhythmia is believed to be in the activating effect of
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Na7H+ antiport by aradrenergic stimulation. The enhanced activity of the Na7H+
antiporter results in increased intracellular Na+ concentration, which in turn, could lead to
Ca2+ overload by a net uptake of Ca2+ via the Na7Ca2+ exchange, thus contributing to
generation of arrhythmia.
In addition, in simulated ischemic conditions, a,-adrenergic receptor-mediated
production of arrhythmia is significantly reduced by WB-4101, a selective a1A-antagonist
(Anyukhovsky and Rosen ,1991). As mention above, the cc1A- subtype is related to the
generation of Ins(l,4,5)P3, which has been observed to be significantly increased
immediately after reperfusion (Mouton R et ah, 1991). Therefore, it is reasonable to infer
that Ins(l,4,5)P3 also contribute to generation of arrhythmias. Thus, Ins(l,4,5)P3 may
play a role as a second messenger in ischemia/reperfusion-induced arrhythmia.
Myocardial a,-adrenergic receptors also play a role in cardiac hypertrophy as seen
in hypertension and myocardial infarction. Norepinephrine has been shown to increase
protein synthesis in cultured rat myocytes (Simpson 1986). Furthermore, aradrenergic
activation activate the expression of protooncogenes, such as c-myc and c-fos, which may
be useful markers for cardiac diseases (Thorburn et al, 1994).
Hypoxia has been shown to increase myocardial a,-adrenergic receptor density in
neonatal rat ventricular myocytes (Kagiya T et ah, 1991). However, others (Steinberg et
al 1993) have shown that the density of aradrenergic receptor was similar in normoxic
and hypoxic cultured myocytes. Steinberg et al also showed that hypoxia stimulates
production of inositol phosphates by stimulation of the a1A-subtype. Heather et al. (1989)
showed that canine myocytes exhibit an increase in the production of Ins(l,4,5)P3 in
response to norepinephrine production following exposure to hypoxia for 10 min.
Further study on the hypoxic effect on myocardial a,-adrenergic receptors is needed to
understand the mechanism of the effect.
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Previous in vivo studies in our laboratory have shown that long-term high-altitude
hypoxemia significantly depressed fetal right ventricular function, with only slightly
decreased left ventricular function, resulting in a reduction in cardiac output (Kamitomo
et al, 1992). Right ventricular sensitivity to afterload was also decreased. However, little
is known in regard to the effect of long-term hypoxemia on a,-adrenergic receptors and
the related second messenger system. Therefore, studies are proposed to further
investigate myocardial a!-adrenergic receptors in response to both long-term hypoxemia
and development. Specific experiments are designed to examine (1) the dose-response
relationship to an a!-adrenergic agonist such as phenylephrine in isolated electrically
driven papillary muscles from sheep myocardium, (2) the dose-response relationship to
p- adrenergic agonist such as isopreterenol with or without prior stimulation of
phenylephrine to demonstrate receptor interactions between these two receptor systems,
(3) myocardial aj-adrenergic receptor density and affinity, and (4) the changes of
Ins(l,4,5)P3 production in response to ccj-adrenergic stimulation in the papillary muscle
preparations in sheep myocardium. These studies should contribute to the understanding
of the mechanisms involved in modulation of cardiac adrenergic systems by both long
term hypoxemia and development.
Conclusion: In summary, myocardial a,-adrenergic receptors have shown to have
diverse effects ranging from physiologic inotropism to pathologic arrythmogenesis.
Ins(l,4,5)P3 and protein kinase C appear to be the second-messengers mediating signal
transduction and linking a,-adrenergic receptor activation to positive inotropism.
Myocardial a,-adrenergic receptors exhibit changes to development and hypoxia. Further
study is needed to clarify the clinical implication of the myocardial a,-adrenergic
receptor system.
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ABSTRACT
To determine the developmental changes in myocardial a,-adrenergic receptor
system, we employed [3H-Prazosin] binding technique to characterize a,-adrenergic
receptors in both fetal and adult sheep myocardial ventricular membrane preparations.
We also measured the inotropic effect of phenylephrine in the isolated electrically driven
papillary muscle preparations in these animals, two groups of animals (n=6-8 in each
group) were tested: (1) Fetal hearts taken from pregnant ewes kept at sea level (300 m)
during the whole gestation (2) Adult hearts taken from non-pregnant adult sheep kept at
sea level. Our finding indicated an age-related differences in a,-adrenergic receptor
density (Bmax in fmol/mg protein), but not in affinity (Kd in nM). Myocardial a,adrenergic receptor density (Bmax) declined during developmental process with both
fetal left ventricle(LV) and fetal right ventricle(RV) having significantly more binding
sites (22.32 ± 2.58 for LV and 29.61 ± 3.42 for RV) than respective adult ventricles
(11.09 ± 1.44 for LV and 10.29 ± 2.06 for RV). There is no ventricular difference in
neither Bmax nor Kd. We also demonstrated that the positive inotropic response to the
a,-adrenergic agonist phenylephrine did not differ significantly between the fetal and
adult ventricles. However, when comparing left ventricle with right ventricle either in the
adult or in the fetuses, we found that the right ventricle had much more pronounced
response to phenylephrine stimulation than the left ventricle. We speculate that changes
in myocardial a,-adrenergic receptor system might be due to modifications in ar
adrenergic receptor subtypes, with resultant changes downstream in the inositol-1,4,5triphosphate and Protein Kinase C pathways. In conclusion, myocardial a,-adrenergic
receptor density was decreased as result of development. The positive inotropic response
to phenylephrine stimulation did not change with increasing age.
Key words: inotropism, phenylephrine, receptor density
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INTRODUCTION
Since the first observation of the existence of aradrenergic receptors in the
mammalian heart by Wenzel and Su in 1966 (35), many studies have investigated the
important role of this receptor system on myocardial contractility and signal transduction
pathways. These studies provide insight into the possible mechanism by identifying
molecular mediators such as a Gh protein and a novel transcription factor linking ot,adrenergic receptors to a phosphalipase c (1,10). Previous studies (5,9,17,32) imply not
only the presence of a,-adrenergic receptors on cardiac muscle of various species, but
also demonstrate that they are coupled to positive inotropic effects and second messenger
systems such as Ins-1,4,5-Triphosphate and Protein Kinase C.
The myocardial a,-adrenergic receptor number varies with species and changes
during the developmental process with greater density in the newborn than in the adult
(4,8). Nakanishi et al (22) showed that myocardial alpha-receptor density decreases and
the positive inotropic effect of the alpha-agonist increases with development. They also
demonstrated the role of Protein Kinase C in the reduced inotropy of alpha-agents in the
newborn animals. In contrast, Endoh et al (8) demonstrated characteristic aradrenergic
receptor binding sites in the dog heart but failed to show any positive inotropic response
to activation of the receptors.
Very few studies have been done on the a,-adrenergic receptor system in the fetal
heart. Little is known regarding the effect of development on myocardial a,-adrenergic
receptors and agonist inotropic effect in the sheep myocardium. The present study was
designed to investigate (1) the inotropic effect of a,-adrenergic stimulation by
phenylephrine in the isolated papillary muscle preparation of developing sheep
myocardium, and (2) the changes of myocardial a,-adrenergic receptor density and
affinity in both near-term fetuses and adults.
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MATERIALS AND METHODS
Animal Preparation: Time-dated pregnant (fetus) and non-pregnant (adults) sheep were
used in this study and were from a single supplier (Nebeker Ranch, Lancaster, CA).
When the pregnant sheep were near-term (140-142 days), animals were transported to our
laboratory at Loma Linda University Medical Center. On the experimental days, the
pregnant ewes were anesthetized by an intravenous injection of thiopental (10 mg/kg) and
then were ventilated with halothane 5% in oxygen. The fetuses were delivered through
midline laparotomy. The hearts were excised from chest cavity and used for either a
mechanical functional study or biochemical determination.
Contractile study: Both left and right ventricles were opened and papillary muscles
were identified and cut into thin strips (0.8-1.0 mm in diameter and 10 mm in length)
under a dissection microscope. Small loops of fine suture were tied around each end of
the muscle strips. They were then dissected free and mounted vertically between a fixed
hook and a force transducer (Grass Inst., Model FT 03, Qincy, MA) in 8 ml muscle baths
continuously bubbled with 95% 02 and 5% C02. The muscle strips were continuously
superfused with Tyrode solution at 35°C and were stimulated via two longitudinal
platinum electrodes at a frequency of 0.8 Hz (Grass Inst., model S/88) using 7 ms squarewave pulses at a stimulation voltage of approximately 40-60 V. Muscle contractions
were recorded on an eight-channel polygraph (Gould Electronics Model RS 3800,
Cleveland, OH) and stored on an on-line computer by using Real Time Data Acquisition
(RTD) software developed in our laboratory (6). The following parameters of mechanical
function were monitored continuously: Tmax (maximal active tension, g/mm2), +dT/dt
(rate of contraction, g/mm2/sec.) and -dT/dt (rate of relaxation, g/mnf/sec.). Muscle

18
contractions were normalized to the cross-sectional area and standardized to percent of
baseline.
Papillary muscles strips were allowed to stabilize for at least one hour in 35°C Tyrode
solution containing (in mM): 2.0 CaCl2, 140 NaCl, 20 NaHC03, 6 KC1, 1 MgCl2, 10
glucose and 5 HEPES (N-2-hydrosyethylpiperazine-N’-2 ethanesulfonic acid), pH = 7.4,
until mechanical stabilization was achieved. All the experiments were performed at
Lmax, the muscle length at which the development of active tension was maximal.
Muscle strips were incubated in 10'6M propranolol for 30 min. to block p-adrenergic
receptors. Then the muscles were stimulated with phenylephrine in one log unit
increments.

Binding Study: Cardiac membrane preparation was done by a modification of Karliner
et al (13). The muscle strips were suspended and minced in 10 volumes of ice-cold
homogenization buffer (50 mM Tris with 1 mM EDTA, pH=7.4, at 4 °C). The muscles
were homogenized in a Polytron homogenizer at a setting of 5 for 10 s, three times total
with at least 1 min. cooling period in between. Then they were centrifuged at 600xg at
4 °C for 15 min. to eliminate tissue debris. The supernatant from the low speed
centrifugation was centrifuged at 39,100 xg at 4 °C for 30 min. The final pellet was
resuspended in 1 ml ice-cold incubation buffer (50 mM Tris, 4 mM Mg2+, pH=7.4).
Protein content was determined using the methods of Lowry, et al (16).
The binding assay was done in duplicate with 3H-Prazosin (specific activity
72.2 Ci/mmol, NET-823 PRAZOSIN[7-Methoxy-3H]- New England Nuclear) as a ligand
to characterize the a,-adrenergic receptors in the presence (total binding) and absence
(nonspecific binding) of 10 pM phentolamine. The final volume of the incubation
medium was 250 pi containing 150 pi of membrane suspension, 40 pi of eight increasing
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concentrations of 3H-Prazosin (0.05 - 2.5 nM) and 50 jal or 60 fal incubation buffer with
and without 10 jal phentolamine. The maximal number of a,-adrenergic receptor binding
sites (Bmax) and the dissociation constant (Kd) were determined using a non-linear
regression one-site binding isotherm and Scatchard analysis.

Materials: Phenylephrine, phentolamine and propranolol were obtained from Sigma
Chemicals (St. Louis, MO) and were of reagent grade. [3H-Prazosin] (78.0 Ci/mmol) was
purchased from DuPont-NEN (Boston, MA).
Statistical Analysis: Results were expressed as means ± SEM. Statistical significance
between the groups was determined by One-way Analysis of Variance with StudentNewman-Keul's multiple comparison test. A p value less than 0.05 was considered an
indication of statistical significance.

RESULTS
Figure 1 shows the contractile response to phenylephrine. In the adult left ventricle
(Panel A), phenylephrine increased maximal tension (Tmax) in a dose-dependent manner
to a maximum of 151 ± 7% of baseline. Although the fetal left ventricular response was
slightly lower (137 ± 9% ), it was not significantly so. In the adult right ventricle
(Panel B), the response to phynelephrine was more robust, reaching a maximum of Tmax
(218 ± 19% ) of baseline. Again the fetal right ventricular response (194 ± 20%) was not
different than that of the adult. Responses to phenylephrine in the rate of contraction
(+dT/dt) and rate of relaxation (-dT/dt) were similar to that seen for maximal tension
(Tmax). The negative log concentration at which half maximal response was achieved,
i.e. (-LogEC50), did not differ significantly among these groups. Average values were:
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adult left ventricle (5.22 ± 0.10), adult right ventricle (5.10 ± 0.02), fetal left ventricle
(5.03 ± 0.04) and fetal right ventricle (4.73 ± 0.08).
Representative saturation binding curves of 3H-Prazosin are shown in Figure 2.
Table 1 shows the comparison of receptor density (Bmax) and dissociation constant (Kd)
among all the groups. Bmax in the fetuses was significantly greater than in the adults and
this difference was present in both ventricles. There were also age-related differences in
dissociation constant (Kd). Comparing left ventricle (LV) with right ventricle (RV) in
both fetuses and adults, no significant changes were detected in Bmax or Kd (Table 1).

DISCUSSION
The major findings in the present study were that a,-adrenergic receptor density
decrease with development, but positive inotropic response to phenylephrine stimulation
did not differ significantly between the fatal and adult myocardium. We also
demonstrated that the right ventricle in both fetus and adult had a much greater response
to phenylephrine than the left ventricle.
Our results from the a,-adrenergic receptor binding experiments are in agreement
with previous studies by other investigators. The values we found for Bmax in adult left
ventricle (11.09 ± 1.44 fmol/mg protein) and right ventricle (10.29 ± 2.06 fmol/mg
protein) (Table 1) compare favorably to values reported previously for adult rabbit
ventricle (8.3 ± 1.1 fmol/mg protein) and adult dog (13.0 ± 1.0 fmol/mg protein) (31).
However, adult rat ventricle Bmax has been reported to be extremely high (67.0 ±5.0
fmol/mg protein) (18,25).
Our finding of a much higher number of a,-adrenergic receptor binding sites in the
fetus than the adult (Table 1), is also in agreement with previous literature. Cheny et al.
(5) has shown that a,-adrenergic receptor density in the sheep declined with development
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from fetus to neonate. Although species differences exist among dogs, rats, man and
sheep with regard to the effects of development on aj-adrenergic receptor density, most
species are in accordance with the trend showing declined a,-adrenergic receptor density
with development (4,23). Kimball et al (15) have shown in the rat cultured myocytes that
the level of a,-adrenergic receptor mRNA as determined by northern blot analysis
decreased with age. Other have shown that in the mouse (31,32) and rat (22,34) the
receptor density increases during fetal life, reaches a peak in the neonate and then
declines in the adult to level equivalent to those observed for the fetus.
Our finding of a positive inotropic response to oq-adrenergic receptor stimulation in
both the fetus and adult is in agreement with similar findings by others (8,9,15,17,22).
We also observed that the maximal response to phenylephrine (Figure 1) did not change
with development inspite of a decrease in receptor density, in agreement with the findings
of Nakanishi et al (22). In addition, we demonstrated that the right ventricle had a greater
inotropic response to phenylephrine stimulation than the left ventricle in both fetal or
adult myocardium. At present, we have no explanation for this ventricular difference.
The apparent age-related increase in inotropic effect of a,-adrenergic receptor
stimulation could be due to changes in the second messenger system such as Ins-1,4,5triphosphate and Protein Kinase C in signal transduction pathway. It is well recognized
that mediators such as Ins-1,4,5-triphosphate and diacylglycerol are involved in the
positive inotropic effect of cq-adrenergic stimulation (2,19,20). Myocardial a,adrenergic stimulation causes hydrolysis of phosphotidylinositol biphosphate to form
Ins(l,4,5)P3 which activates calcium release from intracellular stores (15,24,27,28,30).
Diacylglycerol activates Protein Kinase C which is also involved in muscle contraction.
Nakanishi et al (22) showed that Protein Kinase C activation produced greater negative
inotropy in the developing myocardium, which may in part explain the relatively smaller
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inotropic effect in relation to the much higher receptor density in the immature heart. We
speculate that adult animals might have higher coupling efficiency, producing higher
levels of Ins-1,4,5-P3 resulting in greater inotropic response in relation to the relatively
lower receptor density in this age group. Nakanishi et al (21) have shown the
sarcoplasmic reticulum is underdeveloped in the premature heart. Therefore, it is
possible that the amount of calcium stored in sarcoplamic reticulum is less, resulting in a
reduced response per number of aradrenergic receptors stimulated. However, recent
studies in our laboratory have demonstrated the sarcoplasmic reticulum of term fetal
sheep to be as functionally mature as in the adult (3).
Simpson et al (29) showed that alpha-receptors play an important role in cardiac
growth. Its role in regulating cardiac growth may be more important in the premature
myocardium. This could partly explain why there should be more abundant ar
adrenergic receptors in the fetal hearts.
It has been shown that both alpha, A and alpha,B adrenergic receptor subtypes play a
role in production of the positive inotropic effect mediated by myocardial a,-adrenergic
receptors (9,14,30,33). Our present study demonstrated significant difference in Kd
between fetus and adult. This indicated that myocardial a,-adrenergic receptor subtypes
were changed during development. However, we did not differentiate alphaIA and alpha,B
subtypes in this study. The actual changes that occur in the signal transduction pathway,
in response to alterations in a,-adrenergic receptors and the receptor subtypes during
developmental process, remain to be elucidated.
In conclusion, myocardial a,-adrenergic receptor density decreased with development
from the fetus to the adult. There was also developmental difference in regard to
dissociation constant. However, the inotropic response to phenylephrine stimulation did
not alter significantly with development. We speculate, changes in the coupling process
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subsequent to receptor stimulation together with alterations in signal transduction
pathway, may be crucial in explaining the developmental difference in myocardial ar
adrenergic receptor system.
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FIGURE LEGENDS
Figure 1. Phenylephrine dose-response curves in sheep myocardium. Panel A: left
ventricle (LV); Panel B: right ventricle (RV). Abbr.: Adult (A), Fetus(F). (n=6).

Figure 2. [3H-Prazosin] saturation binding curves to the membranes derived from
sheep myocardium. Receptor density (Bmax) and dissociation constant (Kd) were
calculated from each binding curve for each experiment. Values presented are means of
duplicate determinations in a single representative experiment. (n=6-8). Panel A:
representative saturation binding curves from the left ventricular (LV) myocardium.
Panel B: representative binding curves from the right ventricular (RV) myocardium.
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Table 1. The maximal number of binding sites (Bmax, fmol/mg) and the dissociation
constant (Kd, nM) calculated from 3H-Prazocin binding study of alpha-adrenergic
receptors in the ovine cardiac membrane fractions.
Bmax (fmol/mg)

Kd (nM)

Fetal LV

CON
HYP

22.32±2.58
17.22±1.16

0.26±0.05
0.22±0.06

Adult LV

CON
HYP

\l.09±\A4'
6.55±1.22*

0.12±0.02
0.21±0.10

Fetal RV

CON
HYP

29.61±3.42
18.73±2.05*

0.42±0.13
0.22±0.05

Adult RV

CON
HYP

10.29±2.06+
6.03±1.46*

0.14±0.03
0.21±0.08

Values are mean ± SE, n = 6-8. Left Ventricle (LV), Right Ventricle (RV), Control
(CON), Hypoxic (HYP). * - significantly different from control value.f - significantly
different from respective fetal LV or RV control value.
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ABSTRACT
The present study investigated the effect of long-term high-altitude hypoxemia on the
a,- and [3,-adrenergic receptor interaction in the heart. The contractility of left ventricular
(TV) and right ventricular (RV) fetal ovine papillary muscles was assessed in both ar
adrenergic receptor agonist phenylephrine (PHE) and p]-adrenergic agonist isoproterenol
(ISO) dose response studies. The interactions between two receptor systems were
examined by prior stimulation of muscles with PHE. Two groups of animals were tested:
(1) hypoxic animals kept at high altitude (3,820 m) from 30 days of gestation to near
term, and (2) normoxic animals kept at sea level Hypoxic left ventricle without prior
PHE stimulation produced greater response to ISO stimulation {maximal tension
developed (Tmax, g/mm2): 1.16 ± 0.18; rate of contraction (+dT/dt, g/mm2/sec.): 10.23 ±
0.89 and rate of relaxation (-dT/dt, g/mm2/sec.): 9.28 ± 1.50)} than normoxic left
ventricle without prior PHE stimulation (0.41 ± 0.05, 3.94 ± 0.71 and 3.18 ± 0.47,
respectively) (p<0.01). In right ventricle without prior PHE treatment, only rate of
relaxation (-dT/dt) was significantly modified by hypoxia with (7.61 ± 2.39) in hypoxic
RV and (3.99 ± 1.15) in normoxic RV. Myocardial a,- and p,- adrenergic antagonistic
interaction was observed only in hypoxic LV; hypoxic LV without prior PHE stimulation
had higher contractility (Tmax: 1.16 ± 0.18; +dT/dt: 10.23 ± 0.89 ; -dT/dt: 9.28 ± 1.50)
than hypoxic LV with prior PHE stimulation (0.30 ± 0.06, 5.15 ± 1.01 and 3.67 ± 0.47,
respectively)(p<0.001). No significant difference regarding receptor interaction was
found in the right ventricle. In conclusion, chronic hypoxemia augmented ISO doseresponses in hypoxic left ventricle. PHE antagonized effects of ISO in hypoxic left
ventricle indicating an a,- and p,- adrenergic interaction during long-term high-altitude
hypoxemia.
Key words: inotropism, receptor interaction, dose-response study
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INTRODUCTION
Many studies investigating a,- and pr adrenergic receptor interaction in the heart
have demonstrated both antagonistic and synergistic interactions between these two
receptor systems. Barrett et al (3) showed that a,- adrenergic receptor stimulation
inhibited accumulation of cellular cAMP in rat cardiac myocytes. Since cAMP is the
second messenger modulating contractility from p,- adrenergic receptor activation,
reduced cAMP production resulted in inhibition of the P,- adrenergic response. This
antagonistic interaction is further supported by direct contractile studies of whole heart
preparations (26,28). These studies indicated a mutual attenuation of the function of both
a,- and p,- adrenergic receptor systems in the heart, in that pr adrenergic stimulation
reduced the a,- adrenergic effect by about 50 %, while a,- adrenergic stimulation
attenuated the pr adrenergic effect to a lesser degree (about 20-25%). On the other hand,
there are studies demonstrating synergism between these two receptor systems.
Butterfield et al (6) showed that a,- adrenergic receptor mediated responses were
potentiated following chronic p,- adrenergic stimulation in the rat heart. Contradictory
findings regarding a,- and pr adrenergic receptor interaction has prompted more
vigorous study in this field.
In the present study, we used phenylephrine as an a,- adrenergic receptor agonist
and isoproterenol as a p(-adrenergic agonist to test the interaction between a,- and
P,- adrenergic systems in the heart. We conducted isoproterenol dose-response studies
with or without prior stimulation with phenylephrine in the fetal ovine papillary muscles.
The purposes of this study were: (1) to investigate the effect of ar adrenergic stimulation
on contractility in the fetal heart, (2) to determine the effects of long-term high-altitude
hypoxemia on a,- adrenergic stimulation, and (3) to determine the effects of ap

35

adrenergic stimulation on the pr adrenergic response in both normoxic and hypoxic
fetuses.

MATERIALS AND METHODS
Pregnant sheep (n^b) were transported to a high-altitude research station
(Barcroft Laboratory, White Mountain Research Station, WMRS, Bishop, CA; elevation
3,820 m, barometric pressure, 480 Torr ) at 30 days of gestation, where they remained
until near term (term = 147 days). Another group of pregnant sheep (n=6), which served
as normoxic controls, were kept at low altitude (300 m) throughout gestation. All the
animals used in this study were time-dated and were obtained from a single supplier
(Nebeker Ranch, Lancaster, CA). At 140-142 days of gestation, both groups were
transported to our laboratory at Loma Linda University Medical Center, where the
hypoxic group was maintained hypoxic (Pa02 = 60 Torr) by nitrogen flow through a non
occlusive tracheal catheter. On the experimental day, the pregnant ewes were
anesthetized by an intravenous injection of thiopental (10 mg/Kg) and were ventilated
with 5% halothane in oxygen. The fetus was delivered through midline laparotomy, and
the heart was rapidly removed and transferred to a dissection dish containing heparinized
Tyrode solution continuously bubbled with 95% 02 and 5% CO 2Both left and right ventricles were opened and papillary muscles were identified
and cut into thin strips (0.8-1.0 mm in diameter and 10 mm in length). Small loops of
fine suture were tied around each end of the muscle strips. The muscle strips were
dissected free and mounted vertically between a fixed hook and a force transducer (Grass
Inst., Nodel FT 03, Qincy, MA) in an 8 ml muscle bath continuously bubbled with 95%
02 and 5% C02. The muscle strips were continuously superfused with Tyrode solution at
35 °C and were stimulated via two longitudinal platinum electrodes at a frequency of 0.8
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Hz (Grass Inst., model S/88) using 7 ms square-wave pulses at a stimulation voltage of
approximately 40-60 V. Muscle contractions were recorded on an eight-channel
polygraph (Gould Electronics Model RS 3800, Cleveland, OH) and stored on computer
using software developed in our laboratory (12). Three parameters were measured:
maximal active tension (Tmax), peak rate of contraction (+dT/dt) and peak rate of
relaxation (-dT/dt). They were normalized by the cross-sectional area of each muscle
strip and standardized to percent of baseline.
The muscles were allowed to stabilize for at least one hour in 35°C Tyrode
solution containing (in mM): 2.0 CaCl2, 140 NaCl, 20 NaHC03, 6 KC1, 1 MgCl2, 10
glucose and 5 HEPES (N-2-hydrosyethylpiperazine-N’-2 ethanesulfonic acid), pH = 7.4.
All the experiments were performed at Lmax, the muscle length at which the
development of active tension was maximal. The dose-response study to phenylephrine
was conducted in the continuous presence of 1 pM of propranolol to block (3,- adrenergic
receptors. Dose-response studies were done in a cumulative manner by increasing the
concentration of agonist in log units. The drug concentrations producing 50% of the
maximal response (EC50) were calculated from these dose-response curves.
Isoproterenol dose-response studies were conducted with or without prior 10 pM
phenylephrine stimulation. 10 pM phenylephrine produced about 50% of the maximal
response.
All chemicals were purchased from Sigma Chemicals, St. Louise, MO. and of
regent grade.
Statistical analysis was done using one-way Analysis of Variance. Post hoc
testing of the analysis of variance was done using Duncan’s Multiple Comparison Test.
A p value less than 0.05 was considered an indication of statistical significance. All data
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were presented as means ± SEM. Values obtained from duplicates of muscle strips from
the same animal were averaged and counted as a single determination.

RESULTS
Phenylephrine dose-response study: Figure 1 shows the phenylephrine dose-response
relationship for maximal tension (Tmax) in normoxic, control fetal ovine papillary
muscle preparations. Phenylephrine produced a positive inotropic response in both
ventricles resulting in an augmentation of Tmax to 137.14 ± 9.05 % of baseline in the left
ventricle and a significantly greater augmentation (p<0.05) in the right ventricle (194.46
± 19.97). However, the pD2 values (-LogECSO) were similar for the left ventricle (5.03 ±
0.04) and the right (4.73 ± 0.08). A phenylephrine concentration of 10 pM was
identified as the appropriate dose ( around EC50) to be used in the subsequent
experiments on receptor interaction. Both rate of contraction (+dT/dt) and rate of
relaxation (-dT/dt) had dose-response curves similar to those of Tmax.
Isoproterenol dose-response study: Isoproterenol stimulation alone increased Tmax
(Figure 2) in both the normoxic and hypoxic left ventricle, with the increase being greater
in the hypoxic left ventricle (Table 1). Findings for +dT/dt and -dT/dt were the same as
for Tmax (Table 1). In the right ventricle, isoproterenol alone augmented Tmax in both
normoxic and hypoxic right ventricle (Figure 2). Although the response of the hypoxic
right ventricle tended to be greater than that in the normoxic right ventricle, the difference
was significant for only -dT/dt (Table 1).
Left and right ventricles exposed to long-term hypoxemia had significantly lower
EC50 values in response to isoproterenol when compared to the normoxic controls
(Table 2), indicating that the sensitivity of papillary muscle to isoproterenol stimulation
was greatly enhanced by hypoxemia.
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Receptor interaction: In the normoxic left ventricle, pretreatment with 10 pM
phenylephrine had no effect on its response to isoproterenol (Figure 2 and Table 1).
However, in the hypoxic left ventricle, pretreatment with phenylephrine significantly
attenuated the response of all parameters to isoproterenol, with resposes reduced to the
level of those observed in the normoxic left ventricle. In the right ventricle, no
significant effect of phenylephrine pretreatment on the isoproterenol response was
observed in either normoxic or hypoxic hearts (Figure 2 and Table 1).

DISCUSSION
The major findings in this study were: (1) phenylephrine exerted a positive
inotropic effect on fetal ovine papillary muscle preparations from normoic left and right
ventricle, (2) the hypoxic left ventricle demonstrated a greater response in developed
tension, rate of contraction and rate of relaxation than normoxic left ventricle to
isoproterenol, and (3) phenylephrine attenuated the positive inotropic effect of
pradrenergic stimulation in the hypoxic fetal left ventricle.
Although the p,- adrenergic receptor system is recognized to be dominant in
modulating myocardial contractility (16,25), our present study demonstrates that the
aradrenergic receptor system is also involved in modulating contractility in fetal
ventricles. Phenylephrine is believed to increase force by increasing both calcium
transient and calcium sensitivity, both by a direct action on the myofilaments and also by
stimulation of Na7H+ exchange leading to an intracellular alkalosis (17).
Our present study also demonstrated a receptor-mediated concentration-dependent
increase in contraction to agonist phenylephrine and isoproterenol stimulation in fetal
ovine papillary muscle. In our study, phenylephrine stimulated muscle to various degrees
(from 121.53% (in normoxic right ventricle) to 187.91% (in hypoxic left ventricle) of
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baseline) in different groups. The highest isoproterenol concentration (IpM) tested in our
study also stimulated muscle to various degree from 123% (in normoxic left ventricle) to
267% baseline (in hypoxic left ventricle). It implied that the two receptor systems
possess different characteristics for their inotropic effects. This was supported by
previous observations (8, 22). Osnes et al (26) showed that myocardial a,-adrenergic
inotropic effects were only half of the (3, -adrenergic effects in rat and rabbit myocardium.
In addition, Aoyagi et al (1) showed that a,-adrenergic and p,- adrenergic receptor mediated inotropism had qualitatively different effects on the time course of contraction
and energetic efficiency, in that isoproterenol shortened the time course and
phenylephrine prolonged the time course. More work needs to be done to determine the
mechanism responsible for the inotropic effects of both a, and p, -adrenergic stimulation.
It is generally accepted that phenylephrine stimulates aj-adrenergic receptors in
the heart, which in turn activate Phospholipase C. This phosphoinositide-specific enzyme
mediates PtdIns(4,5)P2 hydrolysis to generate Ins(l,4,5)P3 and diacylglycerol (DAG)
(2,4,11). Ins(l,4,5)P3 enhances the release of calcium from intracellular stores such as
sarcoplasmic reticulum to enhance contraction. Alpha!-adrenergic receptor stimulation
results in the formation of inositol phosphate in a concentration-dependent manner
similar to that of the inotropic response (15,27). Our result from phenylephrine doseresponse study of contraction showed a concentration-dependent increase in force
generation (Figure 1). It is reasonable to infer that Ins(l,4,5)P3 might be involved in the
phenylephrine concentration-dependent increase in force generation.
Myocardial p,- adrenergic receptors utilize cAMP dependent protein kinase
mediated phosphorylation of calcium channels, troponin and phospholamban, resulting in
enhanced contractility of cardiac muscle (9,13). Our study indicated that both left and
right ventricles under both normoxic and hypoxic conditions had typical concentration-
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dependent increases of contraction in response to isoproterenol stimulation. However,
the hypoxic left ventricle demonstrated the greatest response (Figure 2 and Table 1). We
speculate that long-term high-altitude hypoxemia might initiate changes at the receptor
level, such as increased number of myocardial p,- adrenergic receptors or changes distal
to the receptors, such as increased level of cAMP or protein kinase.
Our data indicated that a,-adrenergic activation antagonized p,-adrenergic
response in the hypoxic fetal left ventricle. Other investigators report similar findings in
regard to the interaction of these two receptors. Buxton et al (7) showed that incubation
of intact myocytes with norepinephrine leads to significantly less cyclic AMP
accumulation than stimulation with either norepinephrine plus prazosin or isoproterenol,
due to activation of cAMP phosphodiesterase. Other studies have also shown that agonist
occupation of a,-adrenergic receptors inhibits p,-adrenergic stimulated cAMP
accumulation, which was attributed to receptor coupling to a guanine nucleotide
inhibitory protein (3,23,24). Further, electrophysiological studies have shown that
myofibrillar responsiveness to Ca2+ is increased with phenylephrine, but decreased with
isoproterenol (14).
In conclusion, our study demonstrated that phenylephrine exerted a positive
inotropic effect in the fetal heart. It also showed that hypoxemia augmented isoproterenol
dose-response in the left ventricle. Finally, a, - adrenergic receptor activation exerted an
antagonizing effect on p,- adrenergic receptor system in fetal left ventricle following
long-term high-altitude hypoxemia.
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FIGURE LEGENDS
Figure 1. Phenylephrine (PHE) dose-response in normoxic, control fetal ovine
papillary muscle preparations (n=6). Left Ventricle (LV), Right Ventricle (RV).

Figure 2. Isoproterenol (ISO) dose-response study in the presence and absence of
phenylephrine (PHE) in left ventricle (LV) {Panel A) and right ventricle (RV) {Panel
B). (PHE+ISO) indicates isoproterenol dose-response study with prior stimulation of 10
pM phenylephrine. (ISO ONLY) indicates isoproterenol dose-response study without
prior stimulation of 10 pM phenylephrine.

Table 1. Tmax, +dT/dt, and -dT/dt to maximal isoproterenol stimulation in the presence (PHE+ISO) and absence (ISO
ONLY) of 10 pM Phenylephrine in fetal ovine papillary muscle strips.
Tmax
(g/mm2)

+dT/dt
(g/sec/mm2)

-dT/dt
(g/sec/mm2)

LV (ISO ONLY)

Normoxic
Hypoxic

0.41±0.05
1.16±0.18*

3.94±0.71
10.23±0.89*

3.18±0.47
9.28±1.50*

LV (PHE+ISO)

Normoxic
Hypoxic

0.44+0.12
0.30±0.06t

3.43+0.63
5.15+1.01'

3.25±0.45
3.67±0.47t

RV (ISO ONLY)

Normoxic
Hypoxic

0.61+0.11
0.92+0.31

4.83+1.05
7.89+2.38

3.99+1.15
7.61+2.39*

RV (PHE+ISO)

Normoxic
Hypoxic

0.40+0.13
0.50+0.08

2.20+0.34
4.72+0.55*

1.87+0.32
4.42+0.42

Values are mean ± SE, n = 6-8. Isoproterenol (ISO), Phenylephrine (PHE), Left Ventricle (LV), Right Ventricle (RV).
* - significantly different from respective normoxic value (p<0.05),1 - significantly different from respective LV (ISO
ONLY) value (p<0.05).
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Table 2. LogECSO for Tmax, +dT/dt, and -dT/dt from Isoproterenol dose-response in the presence (PHE+ISO) or
absence (ISO ONLY) of 10 pM Phenylephrine in fetal ovine paillary muscel strips.
Tmax
(g/mm2)

+dT/dt
(g/sec/mm2)

-dT/dt
(g/sec/mm2)

LV (ISO ONLY)

Normoxic
Hypoxic

-6.44±0.27
-7.65±0.13*

-6.53±0.26
-7.76±0.04*

-6.54±0.25
-7.59±0.19*

LV (PHE+ISO)

Normoxic
Hypoxic

-6.32+0.21
-7.82+0.14*

-6.57+0.15
-7.55+0.20*

-6.51+0.14
-7.59+0.26*

RV (ISO ONLY)

Normoxic
Hypoxic

-6.72+0.17
-7.42+0.21*

-6.79+0.21
-7.39+0.18*

-6.73+0.18
-7.50+0.35*

RV (PHE+ISO)

Normoxic
Hypoxic

-6.75+0.14
-7.59+0.29*

-6.04+0.15
-7.32+0.27*

-6.31+0.13
-7.42+0.25*

Values are mean ± SE, n = 6-8. Isoproterenol (ISO), Phenylephrine (PHE), Left Ventricle (LV), Right Ventricle (RV).
* - significantly different from respective normoxic value (p<0.05).
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Figure 1. Phenylephrine dose-response in normoxic, control fetal ovine papillary
muscle preparations (n = 6). Left Ventricle (LV), Right Ventricle (RV).
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ABSTRACT
To determine the effects of long-term high-altitude hypoxemia on myocardial
a,-adrenergic receptor system and Ins(l,4,5)P3 (IP3) responses, we employed
[3H-Prazosin] binding technique and Ins(l,4,5)P3assay to characterize aradrenergic
receptors and Ins(l,4,5)P3 in the sheep myocardial preparations. Two groups of animals
(n=6-8 in each group) were tested: (1) hypoxic fetal hearts harvested from pregnant ewes
kept at high altitude (3,820 m) from 30 days of gestation to near term (140-142 days),
(2) control fetal hearts taken from pregnant ewes kept at sea level (300 m) during the
whole gestation period. Long-term high-altitude hypoxemia significantly depressed
myocardial a,-adrenergic receptor density (Bmax in fmol/mg) in fetal right ventricle
(RV) (18.73 ± 2.05 vs. 29.61 ± 3.42). In contrast, it did not affect the dissociation
constant (Kd). Long-term hypoxemia also significantly decreased Ins(l,4,5)P3production
in response to phenylephrine stimulation in the fetal right ventricle (hypoxic RV
176.58 ± 11.31 vs normoxic RV 300.90 ± 26.95, pmol/mg protein). There is no
ventricular difference in neither Bmax nor Kd. Normoxic right ventricle has the highest
Ins( 1,4,5)P3 production among all the groups. In conclusion, myocardial otj-adrenergic
receptor density and Ins(l,4,5)P3production in response to agonist stimulation in the fetal
right ventricle were decreased as result of long-term high-altitude hypoxemia. We
speculate that changes in myocardial a,-adrenergic receptor system as result of
hypoxemia cause modifications in the signal transduction pathway such as Ins(l,4,5)P3
production.

Key words: binding study, inotropism, time-course study, papillary muscle
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INTRODUCTION
Since the first observation of the existence of a!-adrenergic receptors in the
mammalian heart by Wenzel and Su in 1966 (30), many studies have investigated the
effect of a,-adrenergic receptors on myocardial contractility and also the relationship
between the receptor system and the second messenger system, such as Ins(l,4,5)P3
(1,6,14). These studies prove not only the presence of a,-adrenergic receptors on cardiac
muscle of various species such as guinea pigs, rabbits, cats, lambs, monkeys and human
(4,21), but also demonstrate that they are coupled to Ins(l,4,5)P3and to positive inotropic
responses to agonist stimulation. (16,28).
Myocardial a,-adrenergic receptor number varies from species to species and changes
during the developmental process with greater density in the newborn than in the adult
(3,7,19). Studies of the effects of perturbations, such as hypoxia on a,-adrenergic
receptors have been relatively sparse. Kagiya et al (9) demonstrated in rat cardiac
myocytes that hypoxia significantly decreased norepinephrine binding affinity. Steinberg
et al (26) have shown that the density of a,-adrenergic receptors was similar in normoxic
and hypoxic myocytes, however these studies were done in short-term (2 hr.) hypoxic
conditions. Nothing is known regarding the effect of long-term hypoxemia on
myocardial a,-adrenergic receptors and Ins(l,4,5)P3 production in the fetal heart. The
present study was designed to investigate (1) the effect of long-term high-altitude
hypoxemia on a,-adrenergic receptor density and affinity in the fetal heart, and (2) the
effect of long-term high-altitude hypoxemia on Ins(l,4,5)P3 production in the fetal heart.
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MATERIALS AND METHODS
Animal Preparation: Groups of pregnant sheep (n=6-8) at 30 days of gestation were
transported to Bacroft Laboratory, White Mountain Research Station, WMRS (elevation
3,820 m, barometric pressure, 480 Torr). These animals were kept at the high-altitude
station for 110 days. A group of pregnant sheep kept at sea level served as normoxic
controls. All animals used in this study were time-dated and were from a single supplier
Nebeker Ranch, Lancaster, CA. When these animals were near-term (140-142 days),
they were transported to our laboratory at Loma Linda University Medical Center and
maintained hypoxemic (PaO2=60 Torr) by nitrogen flow through a non-occlusive tracheal
catheter for the hypoxic group. On the experimental days, the pregnant ewes were
anesthetized by an intravenous injection of thiopental (10 mg/kg) and ventilated with
halothane 5% in oxygen. The fetuses were delivered through midline laparotomy, the
hearts were excised from chest cavity, and free wall strips (~ 1 gram) were cut from both
left and right ventricles and frozen at -70°C for radioligand binding studies. Papillary
muscles were cut into thin strips for Ins(l,4,5)P3 studies.

Radioligand binding Study: Cardiac membrane preparation was done by a
modification of Karliner, et al (12). The muscle strips were suspended and minced in
10 volumes of ice-cold homogenization buffer (50 mM Tris with 1 mM EDTA, pLUT.d,
at 4 °C). The muscles were homogenized in a Polytron homogenizer at a setting of 5 for
10 s, three times total with at least 1 min. cooling period in between. Then they were
centrifuged at 600xg at 4 °C for 15 min. to eliminate tissue debris. The supernatant from
the low speed centrifugation was centrifuged at 39,100 xg at 4 °C for 30 min. The final
pellet was resuspended in 1 ml ice-cold incubation buffer (50 mM Tris, 4 mM Mg2+,
pH=7.4 ). Protein content was determined using the methods of Lowry, et al (15).
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The binding assay was done in duplicate with 3H-Prazosin (specific activity
72.2 Ci/mmol, NET-823 PRAZOSIN[7-Methoxy-3H]- New England Nuclear) as a ligand
to characterize the a!-adrenergic receptors in the presence (total binding) and absence
(nonspecific binding) of 10 pM phentolamine. The final volume of the incubation
medium was 250 pi containing 150 pi of membrane suspension, 40 pi of eight increasing
concentrations of 3H-Prazosin (0.05 - 2.5 nM) and 50 pi or 60 pi incubation buffer with
and without phentolamine. The maximal number a,-adrenergic receptor binding sites
(Bmax) and the dissociation constant (Kd) were determined using a non-linear regression
one-site binding isotherm and analysis.

Contractile study: Both left and right ventricles were opened and papillary muscles
were identified and cut into thin strips (0.8-1.0 mm in diameter and 10 mm in length)
under a dissection microscope. A set of eight muscle strips from the left ventricle in each
hypoxic fetus were used for the simultaneous mechanical time-course study of both
tension and Ins(l,4,5)P3. Small loops of fine suture were tied around each end of the
muscle strips. They were then dissected free and mounted vertically between a fixed
hook and a force transducer (Grass Inst., Model FT 03, Qincy, MA) in 8 ml muscle baths
continuously bubbled with 95% 02 and 5% C02. The muscle strips were continuously
superftised with Tyrode solution at 35°C and were stimulated via two longitudinal
platinum electrodes at a frequency of 0.8 Hz (Grass Inst., model S/88) using 7 ms squarewave pulses at a stimulation voltage of approximately 40-60 V. Muscle contractions
were recorded on an eight-channel polygraph (Gould Electronics Model RS 3800,
Cleveland, OH) and on computer using Real Time Data Acquisition (RTD) software
developed in our laboratory (5). Maximal active tension (Tmax) was measured and
standardized to percent of baseline.
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The muscles were allowed to stabilize for at least one hour in 35°C Tyrode solution
containing (in mM): 2.0 CaCl2, 140 NaCl, 20 NaHC03, 6 KC1, 1 MgCl2, 10 glucose and
5 HEPES (N-2-hydrosyethylpiperazine-N,-2 ethanesulfonic acid), pH = 7.4, until
mechanical stabilization was achieved. All the experiments were performed at Lmax, the
muscle length at which the development of active tension was maximal. Muscle strips
were incubated in 10'6M propranolol for 30 min. to block |3-adrenergic receptors. Then
the muscles were stimulated with 10'4M phenylephrine for various time (0.5 - 15 min.).
At the end of each time point, the maximal tension was recorded and tissues were flash
frozen in liquid N2 for Ins(l,4,5)P3 measurements. Some muscle strips were subjected to
various phenylephrine concentrations (10'3-10"6 M), without Ins(l,4,5)P3 determinations,
to characterize the dose-response relationship between phenylephrine and maximal active
tension production.

Ins(l,4,5)P3 test-tube study: To further test the time course of Ins(l ,4,5)P3 production
following phenylephrine, thin strips of normoxic left ventricular papillary muscle were
excised and placed in borosilicate glass test tubes containing 4 ml of oxygenated Tyrode
solution and 10"6M propranolol. The muscles were not electrically stimulated, but were at
rest throughout the study. After a baseline period (30 min.), 10'4 M phenylephrine was
added to each tube and allowed to incubate for time ranging between 30 - 180 sec., after
which the tissues were flash frozen in liquid N2 for later Ins(l,4,5)P3 analysis.
After determination of the optimal time for peak Ins(l,4,5)P3 production, papillary
muscle strips from the normoxic right ventricle were used to determine the dose-response
relation between Ins(l,4,5)P3 and phenylephrine. The muscles were excised, placed in
test tubes (without electrical stimulation), and exposed to phenylephrine in doses ranging
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from 10'3 - 10'6 M. After 60 sec., the tissues were frozen in liquid N2 for later Ins(l,4,5)P3
determination.
Finally, after determination of the optimal time and concentration of phenylephrine
exposure, Ins(l,4,5)P3 production was measured in left and right ventricular papillary
muscles from both normoxic and hypoxic fetuses. The tissues were excised, placed in
test tubes, not electrically stimulated, and exposed to 100 pM phenylephrine for 60 sec.
In some of the test tubes 10'7M prazosin was added to determine if phenylelphrine
stimulation of Ins( 1,4,5)P3 production was mediated entirely through a,-adrenergic
receptors. At the end of the exposure, tissues were frozen in liquid N2 for later
Ins(l,4,5)P3 determination.

Measurements of Ins(l,4,5)P3 Production: Ins(l,4,5)P3 production in papillary muscles
was measured using the DuPont-NEN [3H]IP3 assay system (Boston, MA). Briefly,
frozen muscle strips were homogenized with Polytron homogenizers in ice-cold 1 M
trichloroacetic acid (TCA) and then centrifuged (2,000 g) for 30 min. at 4°C. The
supernatant was extracted with water saturated ether for two times. [3H] inositol-1,4,5
-triphosphate was added to the extracted samples. The mixture was incubated for 60 min.
at 4°C and then centrifuged (3,500 g) for 30 min. The pellet was suspended in a small
amount of 0.15 M NaOH. With the addition of scintillant, the radioactivity was counted
in a scintillation counter and the amount of Ins(l,4,5)P3 was calculated from the standard
curve.
Material: [3H]inositol phosphate standards were obtained from DuPont-NEN (Boston,
MA). Other chemicals were purchased from Sigma Chemicals, St. Louise, MO. and of
regent grade. All drugs were expressed as molar concentrations in the organ bathing and
test tube solutions.
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Statistical Analysis: Results were expressed as means ± SEM of n preparation (n=5-8).
Statistical significance of the difference between the groups was determined by One-way
Analysis of Variance with Student-Newman-Keul's multiple comparison test. A p value
less than 0.05 was considered an indication of statistical significance.

RESULTS
Radioligand binding study: Representative saturation binding curves of 3H-Prazosin
are shown in Figure 1. Actual values for Bmax and Kd are given in Table 1. In the long
term high-altitude hypoxemia group, a,-adrenergic receptor density (Bmax) was
significantly lower in the hypoxic right ventricle compared to the controls. The fetal left
ventricle demonstrated a small, but insignificant reduction in Bmax. There were no
hypoxemia-related differences in dissociation constant (Kd) in either left or right
ventricle (Table 1).

Time-course and dose-response study: Figure 2 shows the temporal relationship
between contractile force and Ins(l,4,5)P3 production in the isolated electrically driven
papillary muscle preparations from hypoxic fetal left ventricles stimulated with 100 pM

phenylephrine. From a basal Ins(l,4,5)P3 level of 9.51 ± 1.26 pmol/mg protein (n=6)
Ins(l,4,5)P3 production increased rapidly, reaching a maximum at 60 seconds, and
declined thereafter to levels at or below baseline. Contractile force (tension) did not
increase significantly until 2 min. and reached a maximum only after 10-15 minutes.
Figure 3 shows the time-course study of Ins(l,4,5)P3 responses to phenylephrine
(100 pM) stimulation in resting papillary muscles from normoxic fetal left ventricles.
Similar to the electrically stimulated muscle, Ins(l,4,5)P3 rose rapidly from a basal level
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of 9.93 ± 1.63 pmol/mg protein (n=6) to reach a peak at 60 seconds. It returned to basal
levels at 90 sec. and remained at low levels until 180 seconds.
Figure 4 shows the Ins(l,4,5)P3 response to different concentrations of phenylephrine
in papillary muscles from normoxic fetal right ventricles, demonstrating a maximal
production of Ins(l,4,5)P3 at 100 pM phenylephrine. Previously (see Chapter 2, Figure
1), we have demonstrated that fetal papillary muscles from normoxic fetuses achieve
maximum active tension development at 100 pM (10"4M) concentration. Figure 5
demonstrates that maximum active tension development in the left ventricle from hypoxic
fetuses is also achieved at 100 pM (lO^M) phenylephrine.
Based on these and previous data, 100 pM (10'4M) phenylephrine was identified as
the agonist concentration for both the maximal Ins(l,4,5)P3 production and force
generation, with maximal Ins(l,4,5)P3 production occurring at 60 seconds. Therefore, in
all subsequent experiments, 1 O'4 M phenylephrine was used to stimulate muscle strips for
60 sec.

Ins(l,4,5)P3study: Figure 6 shows Ins(l,4,5)P3 production for left and right ventricles
from both control and hypoxic fetuses. Table 2 shows the actual values of Ins(l,4,5)P3
production in response to phenylephrine stimulation. The basal values for both left and
right ventricles in the normoxic fetuses were 10.48 ± 1.24 and 11.63 ± 1.50 pmol/mg
protein (n=6 for each group). The basal values for both hypoxic left and right ventricles
were 9.90 ±2.10 and 11.38 ± 2.06 pmol/mg protein (n=5 for each group). There were no
significant differences in basal Ins(l,4,5)P3 production among the groups. Phenylephrine
stimulated Ins(l,4,5)P3 in the normoxic right ventricle to about 300% of basal level,
whereas it increased to only 180% in the hypoxic right ventricle. In the left ventricle,
phenylephrine stimulated Ins(l,4,5)P3 production to 160-170% in both normoxic and

58
hypoxic fetal hearts. In all the groups tested, prazosin completely abolished
phenylephrine-stimulated Ins(l,4,5)P3 production.

DISCUSSION
The major findings in the present study are: (1) long-term high-altitude hypoxemia
significantly decreased a,-adrenergic receptor density in the fetal right ventricle, but not
the left, (2) long-term high-altitude hypoxemia decreased phenylephrine stimulated
Ins( 1,4,5)P3 production in the fetal right ventricle, (3) a temporal relationships between
Ins(l,4,5)P3 and force existed in the hypoxic left ventricle, and (4) phenylephrinestimulated production of Ins(l,4,5)P3 was entirely aradrenergic receptor mediated.
Previous in vivo studies in our laboratory have shown that long-term high-altitude
hypoxemia significantly depressed fetal right ventricular function, with only slightly
decreased left ventricular function, resulting in a reduction in cardiac output (10,11).
Right ventricular sensitivity to afterload was also decreased. These studies showed that
right ventricular function is more susceptible to long-term hypoxic effects than that of left
ventricle, which was consistent with our present study. We demonstrated a significantly
decreased a,-adrenergic receptor density (Bmax) and Ins(l,4,5)P3 response to agonist
stimulation in the right ventricle of hypoxemic fetuses (Tablel, Figure 6). Our finding
also demonstrated that the normoxic right ventricle had the highest Ins(l,4,5)P3
production among all the groups (Figure 6). It has been well established that a,adrenergic receptors mediate positive inotropism in the myocardium in addition to the
well established role for P-adrenergic receptors (22,23,25). Thus, it is possible that the
reduction in aradrenergic receptors and Ins(l,4,5)P3 production in the hypoxic right
ventricle could contribute to the reduction in right ventricular output observed previously.
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Our time-course study of force and Ins(l,4,5)P3 production (Figure 2) compared
favorably with that of Scholz et al (24). In their study with isolated electrically
stimulated perfused rat hearts, Ins(l,4,5)P3 increased significantly within 1 min. after
stimulation, while force of contraction did not increase until 2 min. later. Thus both
studies demonstrate that the increase in Ins(l,4,5)P3 precedes the increase in force of
contraction. Our finding provided further evidence that the a,-adrenoceptor-mediated
increase in Ins(l,4,5)P3 and force of contraction were causally and temporal related.
However, as shown in Figure 2, the content of Ins(l,4,5)P3 returned to the basal level
after about 5 min. and started to increase again at 15 min., while the agonist-induced
contraction increased continuously and reached maximum at about 10-15 min.. Others
have suggested that Ins(l,4,5)P3-mediated release of Ca++ from sarcoplasmic reticulum
works in initiating contraction, the sustained positive inotropic effect of phenylephrine
may be caused by extracellular Ca++ influx (17,20,21).
It is generally accepted that phenylephrine stimulates a,-adrenergic receptors in the
heart muscle, which in turn activate phospholipase C. This phosphoinositide-specific
enzyme mediates PtdIns(4,5)P2 hydrolysis to generate Ins(l,4,5)P3 and diacylglycerol
(DAG) (2,6). Ins(l,4,5)P3 releases calcium from intracellular stores such as sarcoplasmic
reticulum, to enhance contraction. It has been shown that a,-adrenergic receptor
stimulation results in the formation of inositol phosphate in a concentration-dependent
manner similar to that of the inotropic response (20). This was also evidenced in our
present study in that there were phenylephrine concentration-dependent increases in both
Ins(l,4,5)P3(Figure 4) and force generation (Figure 5). Thus, our study demonstrates a
close correlation between phosphoinositide breakdown and inotropic responses mediated
by a!-adrenergic receptors in the fetal myocardium.
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It has been shown that both alpha,A and alpha, B adrenergic receptor subtypes play a
role in production of the positive inotropic effect mediated by myocardial a,-adrenergic
receptors and Ins(l,4,5)P3 (8,18,27). Steinberg et al (26) showed that Ins(l,4,5)P3
response to norepinephrine under hypoxic conditions was inhibited by prazosin and the
alpha,A antagonist WB-4101 but not by alpha,B antagonist chloroethylclonidine. It has
also been shown that both a,-adrenergic receptor subtypes mediating norepinephrineinduced chronotropy were decreased significantly by hypoxia (13). We did not
differentiate the effect of high-altitude hypoxemia on alpha, A and alpha,B subtypes in the
present study. Further study is needed to address this issue.
In conclusion, we found that long-term high-altitude hypoxemia depressed
myocardial a,-adrenergic receptor density (Bmax) in the fetal right ventricle, but did not
alter the dissociation constant (Kd). Ins(l,4,5)P3 production in response to
phenylephrine-stimulated was decreased in the fetal right ventricle following long-term
high-altitude hypoxemia. We attribute the inhibition in Ins(l,4,5)P3production to the
reduction in the a,-adrenergic receptor number in the fetal right ventricle. We speculate
that the decrease in a,-adrenergic receptor density and Ins(l,4,5)P3 in the fetal right
ventricle during long-term hypoxia may be involved in the reduction in right ventricular
function during long-term hypoxemic exposure.
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FIGURE LEGENDS
Figure 1. [3H-Prazosin] saturation binding curves in fetal myocardium. Receptor
density (Bmax) and dissociation constant (Kd) were calculated from each binding curve
for each experiment and averaged for each group. Panel A: left ventricle (LV), Panel B:
right ventricle (RV). Control (CON), Hypoxia (HYP). n=6-8.

Figure 2. Ins(l,4,5)P3 (IP3) production and force of contraction during 100 pM
phenylephrine stimulation in isolated electrically driven papillary muscle strips
from hypoxic fetal left ventricles (n=6).

Figure 3. Time-course of Ins(l,4,5)P3 (IP3) production during 100 pM
phenylephrine stimulation in resting papillary muscle strips from normoxic fetal left
ventricles (n=4).

Figure 4. Dose-response of Ins(l,4,5)P3 (IP3) to phenylephrine stimulation in resting
papillary muscle strips from normoxic fetal right ventricles (n=4).

Figure 5. Phenylephrine dose-response in isolated electrically driven papillary
muscle strips from hypoxic fetal left ventricles (n=6).

Figure 6. Phenylephrine-stimulated Ins(l,4,5)P3 (IP3) response in left ventricle (LV)
and right ventricle (RV) (n=5-6) in both hypoxic and control fetuses. * significantly
different from control left ventricle and hypoxic right ventricle. Phenylephrine (Phe),
Prazosin(Praz).
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Table 1. Myocardial aradrenergic receptor density (Bmax) and dissociation constant
(Kd) in fetal ovine membrane fractions.
Bmax (fmol/mg)

Kd (nM)

LV

CON
HYP

22.32±2.58
17.22±1.16

0.26±0.05
0.22±0.06

RV

CON
HYP

29.61±3.42
18.73±2.05*

0.42±0.13
0.22±0.05

Values are mean ± SE, n = 6-8. Left Ventricle (LV), Right Ventricle (RV), Control
(CON), Hypoxic (HYP). * - significantly different from control value.
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Table 2. Phenylephrine-stimulated Ins(l,4,5)P3 (IP3) response in left (LV) and right (RV)
ventricle from both hypoxic and control fetuses.
PHE
(pmol/mg protein)

PRAZ+PHE
(pmol/mg protein)

LV

CON
HYP

17.13±1.20
15.85±1.48

7.72±0.84
8.99±0.62

RV

CON
HYP

34.99±3.13*
20.09±1.28

12.74±1.47
9.03±0.72

Values are mean ± SE, n = 5-6. Left Ventricle (LV), Right Ventricle (RV), Control
(CON), Hypoxic (HYP), Phenylephrine (PHE), Prazocin (PRAZ). * - significantly
different from control LV and hypoxic RV (p<0.05).
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CHAPTER 5
CONCLUSION

General
Although chronic hypoxia causes increased perinatal morbidity and mortality,
growth retardation, and low birth weight, the mechanisms underlying these sequelae are
unclear (Jacobs R. et ah, 1988). Previous in vivo studies indicate that long-term highaltitude hypoxemia significantly depresses fetal right ventricular function, but only
slightly decreases left ventricular function, resulting in a reduction in cardiac output
(Kamitomo M. et ah, 1992) suggesting that hypoxia-induced changes in right ventricular
contractility may contribute to altitude related increases in neonatal mortality. In the
study by Kamitomo et al., the duration and intensity of hypoxia was similar to that used
in the present studies; from 30 - 120 days gestation at an altitude of 3,820 m. In this key
study, hypoxia produced no significant differences in left ventricular function as indicated
by ventricular output or responses to increased preload. In contrast, hypoxia significantly
depressed the relation between preload and ventricular output in the right ventricle. In
addition, the slope of the relation between ventricular output and arterial pressure was
also depressed by hypoxia, but only in the right ventricle. These data suggest that
hypoxia preferentially and selectively depressed ventricular function in the right heart.
The mechanisms responsible for this selective effect, however, remain unclear.
Hypoxia could potentially depress right ventricular function by depressing any of
the factors which together determine ventricular output. These include heart rate and
stroke volume, and also preload and afterload which directly influence stroke volume.
The final factor governing ventricular output is myocardial contractility. As
demonstrated by Kamitomo M et al. (1992), chronic hypoxia has no effect on heart rate
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or preload. Although hypoxia has been shown to increase afterload, such increases can
not completely explain the corresponding significant reduction in right ventricular output
(approximately 35% reduction). For example, in the study by Kamitomo, hypoxia
elevated fetal arterial pressure by only A17%, but depressed right ventricular output by
A34%, suggesting that factors other than afterload are involved. Together with the
absence of hypoxic changes in heart rate or preload, these data suggest that hypoxia
depresses right ventricular contractility.
One important modulator of myocardium appears to be the myocardial adrenergic
system, whose presence has been confirmed in many species and has been proposed to
modulate cardiac rhythm and conduction as well as force of contraction (Endoh, M. et al.,
1989). In terms of inotropic effects, ocr and p- adrenergic systems appear to work
together such that the a, component contributes 25% and the p- adrenergic receptor
component accounts for 75% of the final inotropic effect of norepinephrine in the isolated
rat heart (Skomedal et al., 1988). In addition, aradrenergic receptors also appear
involved in changes in gene expression which governs myocardial cell growth (Terzic et
al., 1993).
Given the capacity of the myocardial adrenergic system to modulate myocardial
contractility, it is possible that hypoxia could effect changes in contractility by altering
adrenergic function in the heart. To examine this possibility, a preliminary dose-response
study to methoxamine (an a,-receptor agonist) was performed using right and left
ventricular papillary muscles from normoxia and hypoxic fetuses (Kamitomo M et al.,
unpublished data). Hypoxia had no effects on responses to methoxamine in the left heart
but severely attenuated reactivity to methoxamine in the right heart, and thus reinforced
the view that the observed hypoxic depression of right ventricular function in the fetal
heart could be mediated via selective modulation of the adrenergic system. We therefore
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proposed to further study the myocardial a,-adrenergic receptor system by more
completely characterizing a,-receptor dose-response relations, by measuring a,-receptor
density, by quantifying changes in inositol triphosphate {Ins(l,4,5)P3} responses
following aj-receptor agonist stimulation. We also decided to test the possibility that
changes in adrenergic function in hypoxic hearts involves altered interactions between the
ocj and p,- adrenergic receptor systems by examining interactive effects of a! and

on

dose-response relations. Together, these studies enable a direct assessment of the
hypothesis that hypoxia depresses right ventricular function in the ovine fetus by
selectively depressing adrenergic function.

Conclusions and Discussion
First of all, our studies demonstrated that the a,-adrenergic receptor agonist,
phenylephrine, exerted a positive inotropic effect in the fetal heart. Other investigators
have previously demonstrated similar findings in newborns and adult animals (Nakanishi,
T. et ah, 1989). Our study was the first to confirm the finding in the fetuses. Long-term
high-altitude hypoxemia 1) depressed myocardial a,-adrenergic receptor density (Bmax)
in the fetal right ventricle, but did not alter the dissociation constant (Kd). It is generally
accepted that a,-adrenergic stimulation of myocardial a,- receptors causes hydrolysis of
phosphotidylinositol biphosphate to form Ins(l,4,5)P3, which then activates calcium
release from intracellular stores (Berridge M. J. et ah, 1993). 2) Ins(l,4,5)P3 production in
response to phenylephrine-stimulation was also decreased in the fetal right ventricle
following long-term high-altitude hypoxemia. 3) The ratio between the IP3 response and
the receptor density changed between the Con and Hyp. The ratio between the IP3
response and the receptor density for LV were: 17.13/22.32=0.77 for Con, and
15.85/17.22=0.92 for Hyp. The ratio between the IP3 response and the receptor density
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for RV were: 34.99/29.61=1.18 for Con, and 20.09/18.73=1.07 for Hyp. This ratio is
changed between the Con and Hyp groups in both LV and RV. It demonstrates that
hypoxia has multiple effects: 1) it differentially depresses Bmax in right heart only, and
2) it also non-specifically depresses IP3/Bmax ratio (coupling efficiency). Therefore,
both the changes in density and in coupling are probably involved in the decreased IP3
response. In addition, a,-adrenergic receptors mediate positive inotropism in the
myocardium in addition to the well established role for pr adrenergic receptor systems
(Skomedal M. et al., 1988). The cc,-adrenergic receptor system plays a significant role in
contractility under normal condition. Therefore, during long-term hypoxia, we speculate
that the decrease in a,-adrenergic receptor density and Ins(l,4,5)P3 in the fetal right
ventricle may be involved in the reduction in right ventricular response. A decreased
right ventricular response could in turn explain why cardiac output is reduced following
hypoxia.
Secondly, our findings showed that hypoxemia augmented the dose-response to
the p-adrenergic agonist isoproterenol in isometrically-contracted papillary muscle
preparations from the left ventricle. Studies done in our laboratory have also
demonstrated that there is a 55% increase in right ventricular p-adrenergic receptor
density in hypoxic fetuses, but no change in the left ventricle. However, Both
isoproterenol-stimulated and forskolin-stimulated cAMP levels were 1.4 to 2-fold higher
than the controls in both hypoxic ventricles(Browne V. et al. in press). The up-regulating
effect on p- adrenergic receptor density and cAMP level in the hypoxic right ventricle has
been used to explain the relatively higher sensitivity of this ventricle to afterload changes,
i.e. the elevated arterial pressure in the hypoxic condition (Browne V. et al. in press).
Although there was no change in the left ventricle in regard to p- adrenergic receptor
number, cAMP was obviously elevated in that ventricle. These results strongly suggest
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that hypoxia acts downstream of second-messenger production in the signal transduction
cascade coupled to (3- adrenergic receptor system. Therefore, cAMP-mediated events
such as activation of protein kinase A and phosphorylation of calcium channels, troponin
and phospholamban are expected to be enhanced (Zong, X, et al, 1995). We observed in
the present study, in that hypoxia augmented isoproterenol dose-response in the left
ventricle. As mentioned above, myocardial a, - adrenergic receptor function was
depressed by hypoxia, especially in the right ventricle.
Thirdly, our studies showed that a, - adrenergic receptor activation exerted an
antagonizing effect on (3,- adrenergic receptor system in the fetal left ventricle following
long-term high-altitude hypoxemia. This is also compatible with previous literature
(Buxton I. L. et al., 1986). It has been shown that incubation of intact cardiac myocytes
with norepinephrine leads to significantly less cyclic AMP accumulation than stimulation
with either norepinephrine plus prazosin or isoproterenol, due to activation of cAMP
phosphodiesterase (Buxton I. L. et al., 1986). Electrophysiological studies have indicated
that myofibrillar responsiveness to Ca2+ is increased with phenylephrine, but decreased
with isoproterenol (Endoh M. et al., 1988). Our study only demonstrated the receptor
interaction at the functional level. However, adaptive changes to chronic hypoxia may
have occurred at the level of the receptor, second-messenger mediators such as
Ins(l,4,5)P3, protein kinase C (PKC), cAMP and downstream mediators such as protein
kinase A (PKA) and effector proteins in the contractile apparatus in the myocardium.
Further study is needed to clarify this issue. Our findings regarding adrenergic function
provided new insight into understanding the decreased cardiac output observed in
hypoxic fetuses. Apparently, the myocardial ar adrenergic receptor system was
significantly changed by hypoxia . The down-regulation of the a,-adrenergic receptor
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system in the hypoxic right ventricle could be responsible for reduced right ventricular
output.
Finally, our studies showed that myocardial a,-adrenergic receptor density
decreased during development from the fetus to the adult. The dissociation constants in
the fetus were also different from those in the adult, indicating that myocardial a,adrenergic receptor subtypes may have been changed with development. For a receptor
subtype, its properties will be conserved in different tissues. We can assume that
receptor-binding studies are done under similar conditions, i. e. with the same local ionic
charges and the same charge distribution. Thus, the pharmacological profile of the
receptor subtype (e.g. KD for a particular antagonist) should be the same, regardless of
whether it is derived for tissues containing a single subtype or tissues containing multiple
subtypes. Based on this concept, the difference in KD values can point to the existing of
different receptor subtypes. However, the inotropic response to phenylephrine
stimulation was not significantly altered during development. This may be due to
changes in coupling efficiency of receptors. It may also be caused by existence of spare
receptors in the myocardium of fetuses or adults. Our findings agree with previous
literature (Kimball K.A. et al., 1991). It has been shown in rat cultured myocytes that the
level of a,-adrenergic receptor mRNA, as determined by Northern blot analysis,
decreased with age (Kimball K.A. et al., 1991). Studies have shown that cultured
myocytes can accurately reflect changes in intact muscle (Hryshko, L.V., et al. 1989). In
addition, sarcoplasmic reticulum (SR) is underdeveloped in the premature heart
(Nakanishi T. et al., 1984). Currently, three mechanisms have been proposed to
participate in the positive inotropic effect of a,-adrenoceptor agonists: (a) an indirect
increase in lea inward current, (b) a stimulation of inositol phosphate turnover, and (c) an
increases in myofibrillar responsiveness to Ca2+ (Terzic, A., M. 1993). Release of SR
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Calcium is involved in the regulation of contractility. Therefore, it is possible that the
amount of calcium stored in SR in the premature heart is less, resulting in a reduced
response per number of a,-adrenergic receptors stimulated. This could at least partially
explain why adult hearts contract as vigorously as fetal hearts in response to a,-receptor
stimulation although there are fewer a,-receptors in the adults. We speculate that
changes in the coupling process subsequent to receptor stimulation, together with
alterations in signal transduction pathways, may be crucial in explaining changes that
occur in the myocardial a,-adrenergic receptor system during development.
As shown in Figure 1, stimulation of myocardial a,-adrenergic receptors may
increase the sensitivity of the contractile proteins for Ca2+ (Pathway 1). This is probably
related to activation of Na7H+ exchange and alkalization of the sarcoplasm, which leads
to increased Na7Ca2+ exchange, resulting in increase in [Ca2^. The a, - adrenoceptor
stimulation causes phosphorylation of contractile protein(s) and alkalization by activation
of the Na/H antiport. This in turn causes myofilament Ca-sensitization, which has been a
proposed mechanism underlying the positive inotropic action of a,-adrenergic receptors.
The rapid and transient increase in [Ca2+]j that occurs prior to the generation of force plays
a central role in excitation-contraction coupling in intact cardiac muscle.
In addition, ar adrenergic receptor stimulation activates phospholipase C. The
stimulation of cardiac a,-adrenergic receptors promotes the breakdown of PI, producing
IPS and DAG. IPS as a second-messenger in the a,- adrenergic receptor mediated
inotropic action has been demonstrated by Scholz et al. (1992). They found that the
positive inotropic effect of phenylephrine in rat atria is preceded by a decrease in PIP2
and an increase in IPS. Otani et al. (1988) exposed papillary muscles labeled with
[3H]inositol to 0.1 mM neomycin, a blocker of PIP2 degradation. Neomycin inhibited
[3H] inositol phosphate formation and diminished the inotropic effects normally induced
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by a,- adrenergic receptor agonist. Their study shows that the hydrolysis of PIP2 and
Phopholipase C activation is an essential link in the pharmacomechanical coupling that
follows the binding of the agonist to cardiac

adrenergic receptors. This

phosphoinositide-specific enzyme mediates ptd!ns(4,5)P2 hydrolysis to generate
Ins(l,4,5)P3 and diacylglycerol (DAG) (Pathway 2). Ins(l,4,5)P3 releases calcium from
intracellular stores, such as sarcoplasmic reticulum (SR), to enhance contraction, ap
adrenergic receptor stimulation in the heart also leads to changes in membrane potential
(prolongation of the action potential), phospholamban phosphorylation state, and even
myofilament calcium sensitization (Terzic, A., et al. 1993). Studies have shown that
Ins(l,4,5)P3receptors could be converted from low-affinity to high-affinity binding sites
as a consequence of decreased SR Ca2+ content (Sugiyama T. et al., 1995). Our current
study has shown that Ins(l,4,5)P3 response to a,-adrenergic receptor stimulation is
decreased in the right ventricle in hypoxic fetuses (hypoxic RV 176.58 ± 11.31 vs.
normoxic RV 300.90 ± 26.95, pmol/mg protein). We speculate that the reduction in
Ins(l,4,5)P3response could also be due to a decrease in Ins(l,4,5)P3receptor density and
activity. Thus, SR Ca2+ release is decreased in the hypoxic right ventricle, leading to
decreased myocardial contractility.

Speculations and Future Experiments
PKC is also activated in response to myocardial ar adrenergic receptor
stimulation. PKC participates in the “cross talk” between cAMP and the
polyphosphoinositide signaling cascade. Samson R.A. et al. (1994) has shown that PKC
participates in the “cross talk” between cAMP and the phosphoinositide signaling
pathways. Exposure to the PKC-activating phorbol esters results in suppression of the [3,adrenergic-induced triggered activity in hypertrophic cardiomyopathic preparations
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(Samson R.A. et al., 1994) (Samson R.A. et al., 1994). Our study has shown that
activation of ar adrenergic receptors antagonizes the effect of pr adrenergic receptors in
the hypoxic left ventricle. We speculate that activation of PKC in response to a,adrenergic receptor stimulation depresses cAMP levels in the left ventricle following
hypoxia. In addition, various “cross-talk” regulations in the phosphoinositide-cAMP
signal transduction pathways such as PKC and PKA, Ins(l,4,5)P3and cAMP could also
be modified by hypoxia (Di Marzo, V. et al., 1991).
Hypoxia stimulates gene expression in many organisms. For example, the
erythropoietin gene for red cell production is turned on in response to hypoxia (Baker R.
1984). It has been proposed that oxygen could interact directly with nuclear proteins to
induce binding, or that it could modify proteins bound to DNA to induce transcription of
the erythropoietin gene (Ratcliffe P. et al., 1995). Some genes are transcribed in an
oxygen-dependent manner such as platelet-derived growth factor (3 chain and hypoxically
inducible nuclear factor HIF-1 (Ractcliffe P. et al., 1995). It is reasonable to infer that an
oxygen-sensing system similar to the one involved in erythropoietin regulation exists in
the heart, and that it modifies the myocardial adrenergic receptor system during hypoxia.
In summary, our findings regarding adrenergic function provided new insight into
understanding the decreased cardiac output observed in hypoxic fetuses. Apparently, the
myocardial a,-adrenergic receptor system plays an important role in the hypoxic
condition. The down-regulation of the ocr adrenergic receptor system in the hypoxic right
ventricle was responsible for reduced right ventricular output. We speculate that hypoxia
modifies various receptors, second-messenger mediators and “cross-talk” between the
phosphoinositide-cAMP cascades.
Additional studies are needed to investigate the effects of hypoxia and
development upon adrenergic receptor systems. Levels of a, - adrenergic receptor mRNA
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can be determined by Northern blot analysis. In addition, a,- adrenergic receptor
subtypes such as a1A and a1Bcan be identified by dose-response studies to an ar
adrenergic receptor agonist, by radioligand binding study, and by Ins(l,4,5)P3 studies in
the presence of pharmacologically specific antagonists such as WB4101 and CEC. In
regard to receptor interaction and cross-talk regulation, cAMP levels can be measured in
response to myocardial a,-adrenergic receptor stimulation or Ins(l,4,5)P3and PKC
responses can be detected following stimulation of cAMP production by isoproterenol
and forskolin. These studies should further elucidate the changes in the cardiovascular
system that occur during hypoxia and development.
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